AUTHOR=Hua Qianhui , Xu Hong , Chen Xinyi , Pan Junhang , Peng Ying , Wang Wei , Chen Bin , Jiang Jianmin 

TITLE=How to Effectively Identify Patients With Rifampin-Resistant Tuberculosis in China: Perspectives of Stakeholders Among Service Providers

JOURNAL=Frontiers in Public Health

VOLUME=9

YEAR=2021

URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2021.736632

DOI=10.3389/fpubh.2021.736632

ISSN=2296-2565

ABSTRACT=<p>To evaluate China's current rifampin-resistant tuberculosis (RR-TB) screening strategy from stakeholders' perspectives, the perceptions, attitudes, and interests of 245 stakeholders from three eastern, central, and western China provinces on RR-TB screening strategies, were investigated through stakeholder survey and interview. The attitudes toward three RR-TB screening strategies were statistically different: inclination to choose who to screen (<italic>Z</italic> = 98.477; <italic>P</italic> &lt; 0.001), funding for rapid diagnostic technology screening either by reimbursed health insurance or directly subsidized financial assistance (<italic>Z</italic> = 4.142, <italic>P</italic> &lt; 0.001), and respondents' attitude during RR-TB screening implementation levels (<italic>Z</italic> = 2.380, <italic>P</italic> = 0.017). In conclusion, RR-TB screening scope could be expanded by applying rapid diagnostic technologies. Provinces with different economic status could adjust their screening policies accordingly.</p>